Liposarcoma

Overview

Subtypes and Pathogenesis

1. Well-Differentiated Liposarcoma (WDL) / Atypical Lipomatous Tumor (ALT)

• Most common subtype, listed in order of decreasing frequency (WDL/dedifferentiated > myxoid > pleomorphic).
• Genetics: Amplification of chromosome region 12q13-q15, including the MDM2 gene and CDK4. MDM2 acts as an oncoprotein by promoting p53 proteasomal degradation.
• The terms ALT (extremity/superficial trunk) and WDL (retroperitoneum, mediastinum, paratesticular) describe histologically identical tumors in different anatomic locations - the distinction exists because retroperitoneal tumors are harder to resect and more prone to recurrence.
• Dedifferentiated liposarcoma is a progression variant of WDL; it carries a higher risk of distant metastasis.
• IHC: MDM2 and CDK4 positivity helps distinguish from lipoma and other sarcomas.

2. Myxoid Liposarcoma

• Second most common subtype; ~5% of all soft tissue sarcomas in adults.
• More common in the extremities; tends to affect younger to middle-aged adults.
• Genetics: Translocation t(12;16)(q13;p11) → FUS::DDIT3 fusion gene (rarely EWSR1-DDIT3 from t(12;22)). This arrests adipocyte differentiation → proliferation of primitive mesenchymal cells. Activates MET, RET, and PI3K/Akt pathways.
• Intermediate local recurrence (~20%) and metastatic risk (~50%).
• Unique metastatic pattern: metastasizes to bone and retroperitoneum (unusual for soft tissue sarcomas; other STS metastasize mainly to lung).
• Myxoid liposarcoma is notably radiosensitive and chemosensitive; 10-year disease-specific survival ~87%.
• Round cell liposarcoma = poorly differentiated variant of myxoid liposarcoma; worse prognosis with distant metastasis rates up to 21%.

3. Pleomorphic Liposarcoma

• Least common but most aggressive subtype.
• Genetics: Complex karyotype without consistent/reproducible genetic abnormalities; no known targetable mutations.
• Sheets of anaplastic cells with bizarre nuclei admixed with lipoblasts.
• Predilection for the extremities of adults.
• Frequently metastasizes; poor prognosis.

Histopathology

Clinical Features and Location

Imaging

• Plain radiographs: Usually normal.
• MRI: Best modality. Well-differentiated tumors show characteristic fat signal. Features suggesting malignancy over lipoma: tumor >10 cm, thick septa (>2 mm), non-adipose areas, <75% adipose tissue.
• CT: Used for retroperitoneal tumors. Features suggesting dedifferentiation: hypervascularity, necrosis/cystic change, adjacent organ invasion, focal nodular or water-density areas.
• MRI/CT can distinguish WDL from dedifferentiated tumors but can be difficult in large, heterogeneous lesions.

Treatment

Surgery (Mainstay)

• Extremity tumors (ALT/WDL): Limb-sparing resection with negative margins. Limited resection is appropriate given low metastatic risk. Neoadjuvant/perioperative radiation reduces local recurrence risk.
• Retroperitoneal liposarcoma: Gross complete resection is the principal goal - incomplete resection increases mortality. Traditionally involves resection of contiguous organs. Some advocate complete compartmental resection (spleen, pancreas, diaphragm, adrenal, kidney resected in >50% of cases), though this remains debated. Out-of-compartment recurrences (~15%) would not be prevented by this approach.
• Recurrent retroperitoneal disease: Resection is favored when tumor growth rate is <0.9 cm/month.

Radiation Therapy

• Reduces local recurrence, especially for extremity tumors.
• Preferably given in the neoadjuvant (preoperative) setting.
• Myxoid liposarcoma is particularly radiosensitive.

Chemotherapy

• Role is controversial for most subtypes.
• Myxoid liposarcoma is uniquely chemosensitive (anthracycline-based regimens).
• High-grade tumors: standard first-line is anthracycline-based (doxorubicin ± ifosfamide).
• A 2025 systematic review (PMID: 40257618) evaluated immune checkpoint inhibitors + anthracyclines as a potential first-line regimen for dedifferentiated liposarcoma - emerging evidence for immunotherapy combinations.

Poor Prognostic Indicators

• High histologic grade
• Large tumor size
• Proximal or deep location
• Presence of metastases
• Retroperitoneal location (vs. extremity)
• Dedifferentiated or pleomorphic histology

Key Genetic Summary Table